EU/3/20/2251
About
On 28 February 2020, orphan designation EU/3/20/2251 was granted by the European Commission to YES Pharmaceutical Development Services GmbH, Germany, for artesunate for the treatment of malaria.
The sponsorship was transferred to Amivas Ireland Limited, Ireland in September 2020.
Key facts
Active substance |
Artesunate
|
Disease / condition |
Treatment of malaria
|
Date of first decision |
28/02/2020
|
Outcome |
Positive
|
EU designation number |
EU/3/20/2251
|
Sponsor's contact details
Amivas Ireland Limited
Durands Court 7
Parnell Street
Waterford
Ireland
E-mail: info@amivas.com
Patients' organisations
For contact details of patients’ organisations whose activities are targeted at rare diseases, see:
European Organisation for Rare Diseases (EURORDIS), a non-governmental alliance of patient organisations and individuals active in the field of rare diseases.
Orphanet, a database containing information on rare diseases, which includes a directory of patients’ organisations registered in Europe.